Indication

Peripheral thyrotoxicosis due to MCT8 deficiency

Peripheral thyrotoxicosis due to monocarboxylate transporter 8 (MCT8) deficiency is a hypermetabolic clinical state occurring in individuals with Allan-Herndon-Dudley syndrome, an X-linked genetic disorder caused by pathogenic mutations in the *SLC16A2* gene. Read more about Peripheral thyrotoxicosis due to MCT8 deficiency

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Peripheral thyrotoxicosis due to MCT8 deficiency therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Peripheral thyrotoxicosis due to MCT8 deficiency preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Peripheral thyrotoxicosis due to MCT8 deficiency.

Peripheral thyrotoxicosis due to monocarboxylate transporter 8 (MCT8) deficiency is a hypermetabolic clinical state occurring in individuals with Allan-Herndon-Dudley syndrome, an X-linked genetic disorder caused by pathogenic mutations in the *SLC16A2* gene.

While the loss of functional MCT8 impairs thyroid hormone uptake across the blood-brain barrier—causing central nervous system hypothyroidism and severe neurodevelopmental impairment—non-neural tissues utilize alternate transporters to take up thyroid hormones.

Consequently, marked elevations in circulating free triiodothyronine (T3) excessively stimulate peripheral organ systems, notably the cardiovascular and musculoskeletal systems.

This systemic thyroid hormone excess manifests clinically with chronic tachycardia, progressive muscle wasting, elevated energy expenditure, poor weight gain or failure to thrive, and long-term cardiovascular strain.

Personalize your experience

Follow Peripheral thyrotoxicosis due to MCT8 deficiency and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it